A Case of Pustular Psoriasis with Bullous Pemphigoid

Accession number;06A0338785
Title;A Case of Pustular Psoriasis with Bullous Pemphigoid
Author; HANABUSA MAKIKO (Isikiriseikibyouin) NAKANISHI TAKESHI (Osaka City Univ., Graduate School of Medicine, JPN) TSURUTA DAISUKE (Osaka City Univ., Graduate School of Medicine, JPN) ISHII MASAMITSU (Osaka City Univ., Graduate School of Medicine, JPN)
Journal Title;Skin Research
Journal Code:Z0014C
ISSN:1347-1813
VOL.5;NO.1;PAGE.32-36(2006)
Figure&Table&Reference;FIG.9, REF.15
Pub. Country;Japan
Language;Japanese
Abstract;A 66-year old man, having been diagnosed and treated as psoriasis vulgaris for more than 15 years was admitted to our hospital because of sudden appearance of severe swelling, scales and erythema on almost entire body and accompanied with fever at 39 degrees centigrade. We started treatment with oral etretinate 75 mg daily, improving systemic symptoms and erythema dramatically. However after tapered it to 20mg daily, tense systemic bullae appeared. Histopathologically, there were subepidermal bullae including eosinophils. Direct immunofluorescent test showed linear deposition of immunoglobulin G and C3 at the basement membrane zone. Indirect immunofluorescent test using normal control skin and patient sera revealed that patient sera included IgG type antibody (minimum concentration; 1:160). Indirect immunofluorescent test using normal human skin split by 1M sodium chloride showed that patient sera reacted on the epidermal side. Immunoblot analysis disclosed that the patient sera reacted with bullous pemphigoid antigen of 180kDa. Enzyme-linked immunosorbent assay showed that patient sera was precipitated by recombinant BP180 protein. From these analyses, we diagnosed this patient as bullous pemphigoid accompanied with pustular psoriasis. Combination therapy of etretinate (20mg daily) and cyclosporin (1.5mg/kg daily) gave improvement on his eruption. He is controlled by cyclosporin (1.5mg/kg daily) only, and keeps stable condition. (author abst.)
FULLTEXT